LncRNA ITGB2-AS1NAMPTCisplatin resistance is a major therapeutic challenge in non-small cell lung cancer (NSCLC). Herein, the regulatory role of long non-coding RNA (lncRNA) ITGB2-AS1 in regulating NSCLC cisplatin resistance was investigated. NSCLC cisplatin resistance cells were constructed using...
The lncRNA integrin subunit beta 2 (ITGB2)-anti-sense RNA 1 (ITGB2-AS1) affectsITGB2expression; however, there is a gap in knowledge regarding its expression and clinical usefulness in RA and OA. This study investigated the potential of serumITGB2-AS1as a novel diagnostic biomarker and its...
ITGB2‐AS1miR‐4319PDACprogressionRAF1Long noncoding RNA (lncRNA) has been considered as potentially critical regulators in pancreatic ductal adenocarcinoma (PDAC). In this study, we prospectively investigate the effect and mechanism of lncRNA integrin subunit beta 2゛nti﹕ense RNA 1 (ITGB2〢S1)...
ITGB2-AS1osteosarcomaproliferationmigrationinvasionWnt/beta-catenin signallingOsteosarcoma is the most common and highly aggressive bone neoplasm often occurs among adolescents and young people. In despite of the major advances in the treatment, the overall survival of osteosarcoma patients remains poor. ...
ITGB2-AS1osteosarcomaproliferationmigrationinvasionWnt/β-catenin signallingOsteosarcoma is the most common and highly aggressive bone neoplasm often occurs among adoles- cents and young people. In despite of the major advances in the treatment, the overall survival of osteosarcoma patients remains poor....